On June 22, the launch ceremony of the "Silk Road IP – Opportunity China" International Online Communication Campaign was held at the North Hall of the Radiotherapy Center at the Lanzhou Campus of Gansu Wuwei Cancer Hospital. International influencers from countries along the Silk Road – including Russia, Pakistan, France, Brazil, Mexico, and Uzbekistan – along with representatives from central, provincial, and municipal mainstream media and new media platforms, gathered at the site. They visited China's domestically developed heavy ion clinical treatment center, which operates with fully independent intellectual property rights, and observed firsthand the achievements in technological innovation and industrial development in cancer radiotherapy in Gansu Province, as presented to Belt and Road partner countries.

wuwei

At the event, international influencers – including Yu Xinke, Nadiya, Roman (Russia), Jim (Pakistan), Wei Wuxia (France), Meng Tailong (Brazil), Huang Wenxing (Mexico), and Avela (Uzbekistan) – conducted on‑site visits and interviews. Central and provincial media outlets such as Xinhua News, CNR Online, CRI Online (China Radio International), China Silk Road Channel (China.com.cn), China Gansu Net, ifeng Gansu, New Gansu Client, Daily Gansu Net, and Benliu News, as well as major new media platforms including Douyin, Kuaishou, Weibo, and Toutiao, provided full coverage throughout the event. Together, they built a multi‑platform, multilingual, and comprehensive international communication matrix, presenting the achievements of Gansu's high‑quality healthcare development to overseas audiences from multiple angles and across multiple levels.

wuwei

The Lanzhou Campus of Gansu Wuwei Cancer Hospital is the second clinical heavy ion center in China to operate with domestically developed intellectual property, managed by Gansu Wuwei Cancer Hospital. Building on the experience of more than 2,800 treatment cases at the Wuwei Heavy Ion Center, the Lanzhou center has already completed over 600 photon and heavy ion treatments. Guided by 50 nationally renowned experts, it is forging a new national high ground for heavy ion therapy.

Talent development is the core engine for high‑quality development in healthcare. The hospital has established a high‑level expert workstations, bringing together leading figures in radiotherapy from across the country. The core clinical team includes 50 top domestic experts, such as Professor Shen Wenjiang, Emeritus Professor of the Department of Radiation Oncology at Peking University Health Science Center, and Professor Xu Bo, Standing Committee Member of the Chinese Society of Radiation Oncology. Professor Wang Junjie, Chair of the Chinese Society of Radiation Oncology, serves as the Dean of the Lanzhou Campus. These leading experts regularly participate in multidisciplinary consultations, clinical technical guidance, and cutting‑edge academic exchanges, building a solid talent and technical foundation for high‑precision, standardized heavy ion therapy.

In terms of hardware, the campus is equipped with a comprehensive range of internationally advanced cancer diagnosis and treatment technologies, forming a standardized, intelligent, and precise modern oncology service system. Core equipment includes the Varian VitalBeam medical linear accelerator, the Elekta Infinity four‑dimensional image‑guided radiotherapy linear accelerator, a 3.0T simulation and positioning MRI, a GE 256‑slice high‑end spiral CT, a Varian Iridium‑192 afterloader, and other advanced radiotherapy and imaging devices. This enables precise tumor localization, accurate treatment planning, and precise radiation dose delivery, systematically enhancing the accuracy and safety of cancer care.

wuwei

Following the launch ceremony, Meng Wanbin, Director of the Radiotherapy Physics Department at the hospital, led the international influencers and media reporters on an on‑site tour. The delegation visited the achievements exhibition area in the North Hall, the heavy ion central control room, the heavy ion treatment hall, the physics planning room, the photon therapy hall, the West Hall, and other functional areas. They gained a detailed understanding of the core technical principles of domestically developed heavy ion therapy, standardized clinical workflows, the full‑process quality and safety management system, and the operation and maintenance of various advanced radiotherapy devices. Through this close‑up, comprehensive tour, they experienced the entire service chain of China’s independently developed heavy ion cancer therapy.

wuwei

The “Silk Road IP – Opportunity China” international communication campaign being held at the Lanzhou Campus of Gansu Wuwei Cancer Hospital represents an important opportunity to showcase Gansu’s independent medical science and innovation achievements and to expand international health exchanges through the Silk Road’s external communication channels. Looking ahead, Gansu Wuwei Cancer Hospital will continue to leverage the complementary strengths of its Wuwei and Lanzhou heavy ion centers, deepen international medical exchange and cooperation, and strengthen global communication through overseas influencers and multimedia platforms. The hospital will continue to tell the story of China’s independent innovation in heavy ion technology and its benefits for public health, while building a distinctive health brand along the Silk Road. Through advanced cancer diagnosis and treatment innovations, the hospital aims to contribute to deeper, more substantive Belt and Road cooperation in the health sector.

wuwei